2023 International Congress Archives - Page 173 of 186

Was the deep brain stimulation surgery successful? Is it the same for the physician and the patient ?

M. Contreras Pinto, J. Hortal, S. Torres, M. Ramirez (la serena, Chile)
WATCH-PD: Longitudinal Digital Assessments in Early Parkinson’s Disease

T. Kangarloo, ER. Dorsey, P. Auinger, D. Volfson, P. Padmanabhan, Y. Gong, B. Tracey, D. Stephenson, D. Anderson, J. Severson, M. Kostrzebski, P. Wilmot, Y. Pohlson, J. Cosman, J. Adams (Cambridge, USA)
Wavelet-based bracketing, time-frequency beta-burst detection: new insights in Parkinson’s disease

T. Sil, M. Muthuraman, H. Eldebakey, I. Hanafi, J. Volkmann, M. Reich, R. Peach (Wuerzburg, Germany)
Weighing tremor reduction and side effects: Impact of efficacy and safety outcomes on patient satisfaction at 6 months in MR-guided focused ultrasound thalamotomy for tremor treatment

F. Buechele, S. Mahendran, M. Uhl, C. Freudinger, A. Maric, M. Oertel, C. Baumann, L. Stieglitz (Zurich, Switzerland)
What change to expect in duration of benefit per dose when switching from IR CD-LD to IPX203 (ER CD-LD)

R. Hauser, S. Allard, G. Banisadr, S. Fisher (Tampa, USA)
What do people with parkinsonism consider important and want to achieve?

K. Lloyd, E. Tenison, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)
White matter hyperintensities associated with impulse control disorders in Parkinson’s disease

G. Hernadi, G. Perlaki, M. Kovacs, D. David, G. Orsi, J. Janszky, N. Kovacs (Pécs, Hungary)
White matter integrity in patients with PSP-RS and VaP: A TBSS Study

K. Chatterjee, M. Tiwari, P. Basu, S. Choudhury, H. Kumar (Kolkata, India)
White matter lesion burden is associated with poorer clinical and driving outcomes in mild Parkinson’s disease

E. Uc, V. Magnotta, D. Mcgehee, E. Axelson, M. Mani, J. Dawson, A. Comellas, J. Kline, N. Narayanan, S. Anderson, C. Weber, W. Darling (Iowa City, USA)
White Matter Lesion Characteristics of Patients with Multiple Sclerosis and Parkinsonism

Y. Shi, S. Gadani, K. Mills (Baltimore, USA)
White matter lesions and motor symptoms in Parkinson’s disease

S. Jost, A. Sauerbier, A. Rizos, M. Picillo, D. van Wamelen, V. Stopic, JN. Petry-Schmelzer, M. Schönfeld, N. Abdullayev, K. Ashkan, K. Rukavina, J. Jarosz, M. Sommerauer, M. Qamar, R. Cury, E. Fonoff, M. Dos Santos-Ghilardi, A. Othman, M. Muthuraman, GR. Fink, A. Antonini, L. Timmermann, P. Martinez-Martin, A. Fasano, K. Ray Chaudhuri, H. Dafsari (Cologne, Germany)
Whole exome sequencing of 67 Swedish Parkinson patients identifies a family with VPS35 D620N

E. Kafantari, A. Puschmann (Lund, Sweden)
Why is HAL effective in improving gait and balance function in Parkinson’s disease?

N. Togashi, K. Tateno, Y. Kondo, M. Masanobu, A. Kawanami, K. Hasegawa (Sagamihara, Japan)
Why Me Why Not? Understanding the Perception of Research among African Americans with PD

C. Branson, J. Luc-Rolland, D. Geiger, J. Cook, A. Willis (Atlanta, USA)
Widespread Synuclein pathology in hyposmics precedes dopamine transporter deficit in PARS

K. Marek, D. Russell, L. Concha, C. Caspell-Garcia, E. Brown, M. Brumm, C. Choi, M. Stern, D. Jennings, C. Soto, A. Siderowf (New Haven, USA)
Wilson disease: a single-center study from Tunisia

R. Zouari, R. Amouri, I. Ben Kraiem, MZ. Saeid, F. Nabli, S. Ben Sassi (Tunis, Tunisia)
Women and PD: experienced changes in parkinson symptoms after menopause

W. Kapelle, A. Oosterbaan, E. Stuart, B. Bloem, M. Meinders, B. Post (Nijmegen, Netherlands)
Words Spoken Daily: A Novel Measure of Cognition

S. Lettenberger, M. Zafar, J. Soto, Y. Zhang, G. Zhu, A. Masino, G. Nkrumah, E. Waddell, K. Spear, A. Arky, R. Toor, E. Hartman, J. Epifano, R. Christie, Z. Duan, R. Dorsey (Rochester, USA)
Worsening of Essential Tremor after SARS-CoV-2 infection: 1 year follow up.

D. Costa, L. Angelini, M. Passaretti, D. Birreci, D. Colella, A. Cannavacciuolo, G. Paparella, A. Berardelli, M. Bologna (Rome, Italy)